OGEN
Price:
$0.6
Market Cap:
$2.60M
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus; and Terra CoV-2, an intramuscular vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials rela...[Read more]
Industry
Biotechnology
IPO Date
2004-02-25
Stock Exchange
AMEX
Ticker
OGEN
According to Oragenics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 225.55M. This represents a change of 311.37% compared to the average of 54.83M of the last 4 quarters.
The mean historical Enterprise Value of Oragenics, Inc. over the last ten years is 529.43M. The current 225.55M Enterprise Value has changed 4.16% with respect to the historical average. Over the past ten years (40 quarters), OGEN's Enterprise Value was at its highest in in the March 2021 quarter at 2.77B. The Enterprise Value was at its lowest in in the September 2025 quarter at -10988482.21.
Average
529.43M
Median
373.06M
Minimum
72.84M
Maximum
1.48B
Discovering the peaks and valleys of Oragenics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 208.42%
Maximum Annual Enterprise Value = 1.48B
Minimum Annual Increase = -80.67%
Minimum Annual Enterprise Value = 72.84M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 224.64M | 208.42% |
| 2024 | 72.84M | -80.67% |
| 2023 | 376.86M | 2.06% |
| 2022 | 369.26M | -75.12% |
| 2021 | 1.48B | 99.32% |
| 2020 | 744.73M | 15.26% |
| 2019 | 646.15M | 104.57% |
| 2018 | 315.85M | -7.39% |
| 2017 | 341.07M | -52.53% |
| 2016 | 718.50M | -56.31% |
The current Enterprise Value of Oragenics, Inc. (OGEN) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
224.78M
5-year avg
505.60M
10-year avg
529.43M
Oragenics, Inc.’s Enterprise Value is greater than AIM ImmunoTech Inc. (5.74M), greater than KALA BIO, Inc. (-5181981.00), greater than Ensysce Biosciences, Inc. (-4003642503190.00), greater than Soligenix, Inc. (-4069820.00), greater than Qualigen Therapeutics, Inc. (-11668698.00), less than Can-Fite BioPharma Ltd. (8.88B), greater than Xenetic Biosciences, Inc. (-2744092.00), greater than CNS Pharmaceuticals, Inc. (-5559528.00), greater than Kazia Therapeutics Limited (-38920894.68), less than Titan Pharmaceuticals, Inc. (761.15M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 5.74M | $1.77M | |
| -5181981.00 | $2.38M | |
| -4003642503190.00 | $3.50M | |
| -4069820.00 | $3.51M | |
| -11668698.00 | $5.43M | |
| 8.88B | $1.65M | |
| -2744092.00 | $5.14M | |
| -5559528.00 | $1.31M | |
| -38920894.68 | $21.82M | |
| 761.15M | $3.11M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Oragenics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Oragenics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Oragenics, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Oragenics, Inc. (OGEN)?
What is the 3-year average Enterprise Value for Oragenics, Inc. (OGEN)?
What is the 5-year average Enterprise Value for Oragenics, Inc. (OGEN)?
How does the current Enterprise Value for Oragenics, Inc. (OGEN) compare to its historical average?